Synthesis and antimicrobial activity of some new hydrazone-bridged thiazole-pyrrole derivatives
- 31 May 2012
- journal article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 28 (4) , 830-835
Abstract
In this work, we synthesized fourteen different compounds which contain hydrazone bridged thiazole and pyrrole rings. For this purpose, pyrrole-2-carboxaldehydes were reacted directly with thiosemicarbazide in ethanol and then obtained thiosemicarbazones were condensed with α-bromoacetophenone derivatives (Hantzsch reaction) to give 1-substituted pyrrole-2-carboxaldehyde [4-(4-substituted phenyl)-1,3-thiazol-2-yl] hydrazones. The structures of the obtained compounds were elucidated by using IR, 1H-NMR and FAB+-MS spectral data and elemental analyses results. All of the compounds were screened for their antibacterial and antifungal activities against twelve different microorganisms by using microbroth dilution method. Ketoconazole and chloramphenicol were used as standard drugs. All of the compounds showed good activity against Staphylococcus aureus and Enterococcus faecalis.Keywords
This publication has 19 references indexed in Scilit:
- Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Synthesis and Biological Evaluation of Some 2,4,5‐Trisubstituted Thiazole Derivatives as Potential Antimicrobial and Anticancer AgentsArchiv der Pharmazie, 2008
- Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp.Bioorganic & Medicinal Chemistry Letters, 2007
- Mechanisms of Antimicrobial Resistance in BacteriaThe American Journal of Medicine, 2006
- Amphotericin B and Caspofungin Resistance in Candida glabrata Isolates Recovered from a Critically Ill PatientClinical Infectious Diseases, 2006
- Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve EndocarditisAntimicrobial Agents and Chemotherapy, 2005
- The need for new therapeutic agents: what is in the pipeline?Clinical Microbiology and Infection, 2005
- Trends in Antimicrobial Drug Development: Implications for the FutureClinical Infectious Diseases, 2004
- Caspofungin Resistance inCandida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida EsophagitisAntimicrobial Agents and Chemotherapy, 2004
- The future challenges facing the development of new antimicrobial drugsNature Reviews Drug Discovery, 2002